D.E. Shaw & Co’s Cantel Medical Corporation CMD Stock Holding History

D.E. Shaw & Co’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-7,600	Closed	-$613K	–	4105
2019 Q2	$613K	Buy	7,600 +500	+7%	+$35.2K	﹤0.01%	2970
2019 Q1	$475K	Buy	+7,100	New	+$538K	﹤0.01%	3022
2018 Q3	–	Sell	-5,000	Closed	-$492K	–	4073
2018 Q2	$492K	Sell	5,000 -100	-2%	-$11.2K	﹤0.01%	3128
2018 Q1	$568K	Buy	+5,100	New	+$572K	﹤0.01%	2817
2014 Q1	–	Sell	-12,500	Closed	-$424K	–	4751
2013 Q4	$424K	Buy	+12,500	New	+$433K	﹤0.01%	3822

D.E. Shaw & Co's CMD Position: Q2 2021 in Review

D.E. Shaw & Co sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 407,352 shares — an estimated $32.5M sold.

D.E. Shaw & Co first reported a position in CMD in Q2 2016 and held it in 12 quarters. The position peaked at $32.5M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

D.E. Shaw & Co reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
D.E. Shaw & Co sold 407,352 Cantel Medical Corporation shares in Q2 2021, an estimated $32.5M.
D.E. Shaw & Co first reported a position in Cantel Medical Corporation in Q2 2016 and held it in 12 quarters.
D.E. Shaw & Co's Cantel Medical Corporation position peaked at $32.5M in Q1 2021.
0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on D.E. Shaw & Co's 13F filing for Q2 2021, filed 16 Aug 2021.